CLOV$2.09
$2.10
Chart
Performance
Key Stats
AI CLOV Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyThe company shows potential for growth, supported by improving profitability and a positive outlook on key growth drivers. However, current technical indicators suggest some short-term caution is warranted.
Thematic
Clover Health is positioned within the growing Medicare Advantage market, with a focus on technology-enabled care delivery that addresses key demographic trends.
Fundamental
The company has shown revenue growth but is currently unprofitable on a trailing twelve-month basis. The balance sheet appears to be in a manageable state with decreasing debt.
Technical
The stock is trading below its key moving averages and showing mixed signals from oscillators, indicating a lack of strong upward momentum currently.
| Factor | Score |
|---|---|
| Healthcare Technology Adoption | 80 |
| Demographic Trends (Aging Population) | 85 |
| Regulatory Environment | 60 |
| Competitive Landscape | 70 |
| Factor | Score |
|---|---|
| Valuation | 70 |
| Profitability | 30 |
| Growth | 75 |
| Balance Sheet Health | 90 |
| Cash Flow | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 50 |
| Volume Confirmation | 60 |
| Support & Resistance | 70 |
AI Investing Checklist
Powered by LiveAIBullish Points (6)
Improved Earnings Trends
EPS surprises have been positive in the last two quarters, with the most recent quarter showing a 50.0% positive surprise (reported -0.02 vs estimate -0.04).
Positive Cash Flow from Operations
The company generated positive operating cash flow of $34.85 million in the latest annual period (2024), indicating improved operational efficiency.
Bearish Points (8)
Consistent Net Losses
The company has reported net losses for the past several years, with a net loss of $43.01 million in 2024.
Negative Earnings Per Share
The EPS (TTM) is -0.04, indicating the company is not currently profitable on a per-share basis.
Calendar
August 2025
6
Next Earnings Date
H: $0.03
A: $0.03
L: $0.03
H: 482.50M
A: 468.30M
L: 458.64M
Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.
Seasonals
Price Target
4.69 USD
The 39 analysts offering 1 year price forecasts for CLOV have a max estimate of 6.00 and a min estimate of 3.75.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Largest health insurer with a dominant presence in Medicare Advantage plans and extensive healthcare services through Optum, making it a direct and significant competitor to Clover Health.
Weight: 93
One of the largest providers of Medicare Advantage plans, directly competing with Clover Health in the senior healthcare insurance market.
Weight: 90
Owns Aetna, a major health insurer with a significant Medicare Advantage footprint. Also operates pharmacies and PBM services (Caremark), encompassing various aspects of healthcare delivery and management relevant to Clover.
Weight: 88
Formerly Anthem, it is one of the largest health insurers in the U.S. offering Medicare Advantage plans, positioning it as a direct competitor.